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Introduction
Punctate inner choroidopathy (PIC) is a posterior uveitis belonging to the group of idiopathic white dot syndromes. It tends to present in young to middle aged women with myopia [1] . Choroidal neovascularization (CNV) may develop in the setting of PIC, leading to visual impairment [2] . Optical coherence tomography (OCT) and fluorescein angiography (FA) are most commonly utilized to identify and monitor CNV in patients with PIC.
Optical coherence tomography angiography (OCT-A) is a relatively new, noninvasive imaging modality that had been previously shown to successfully identify CNV in patients with diseases such as neovascular age-related macular degeneration (AMD) before a recently published series demonstrated its utility in PIC [3, 4] . This report highlights the usefulness of OCT-A in cases of PIC to guide management.
Case Presentation
A 29-year-old woman with no prior medical history presented with a new black spot in her right eye and wavy lines in her left eye. Best corrected Snellen visual acuity was finger count in the right eye and 20/40 in the left eye. Anterior chamber examination was unremarkable and trace vitreous cell was noted in both eyes. Fundoscopic exam revealed multiple, small, punched-out variably pigmented lesions in the posterior pole of both eyes with scattered peripheral lesions ( Figure 1 ). OCT (Spectralis HRA + OCT, Heidelberg Engineering, Inc., Heidelberg, Germany) demonstrated RPE disruption and deposition with intraretinal fluid with retinal atrophy in the right eye (Figure 2(a) ) and RPE disruption with subretinal and intraretinal fluid in the left eye (Figure 2(b) ). OCT-A (RTVue-XR Avanti, Optovue, Fremont, CA) at the level of the RPE disruption in both eyes revealed increased abnormal flow consistent with bilateral CNV (Figure 3) . FA (Optos, Optos Inc., Dunfermline, United Kingdom) demonstrated late leakage corresponding to the CNV (Figure 4) . The patient received bilateral intravitreal injections of bevacizumab and was lost to follow-up after a single treatment. that CNV and inflammatory lesions may present similarly with elevation of the retinal pigment epithelium (RPE) and subretinal fluid on OCT and leakage on FA [5] . It is important to be able to differentiate the two, as CNV typically requires prompt treatment with intravitreal antivascular endothelial growth factor (anti-VEGF) agents whereas treatment of inflammatory lesions relies on immunosuppressant therapy [5] . A recently published case series demonstrated the value of OCT-A in detecting CNV in PIC. In some instances, FA was unable to distinguish active inflammation from CNV while OCT-A clearly revealed abnormal flow corresponding to CNV [4] . OCT-A carries the additional advantage of being noninvasive and avoiding potential rare side effects such as anaphylaxis from fluorescein dye.
Discussion
As the technology continues to evolve, OCT-A should continue to provide more information about classically described disease processes such as PIC. In the same case series, OCT-A showed the progression of CNV activity as measured by flow while OCT imaging remained stable [4] . Beyond its ability to simply visualize CNV, in the future OCT-A may ultimately help elucidate how those new vessels respond to anti-VEGF treatment [6] .
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